Back to main

Street research for Supernus Pharmaceuticals expected on May 27

Posted
5/22/2012 7:00:00 AM
By: Renaissance Capital
Referenced Stocks:SUPN

Street research for Supernus Pharmaceuticals, a former Shire sub developing improved drug formulations for epilepsy and ADHD, is expected to be released on 5/27/12. On 4/30/12, the company raised $50.0 million by offering 10,000,000 shares at $5.00. Citi and Piper Jaffray acted as lead managers on the deal.